Valiant Laboratories Ltd share price logo

Valiant Laboratories Share Price

NSE: VALIANTLAB

BSE: 543998

Small Cap

Healthcare Sector

₹57.57

+6.64

(+13.04%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Valiant Laboratories Stock Performance

as on March 19, 2026 at 6:18 pm IST

  • Day's Low

    Day's High

    ₹49.99
    ₹59.98
    downward going graph

    13.17%

    Downside

    4.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹49.51
    ₹115.19
    downward going graph

    14.00%

    Downside

    100.09%

    Upside

    downward going graph

Valiant Laboratories share price movements today

Previous Close
₹50.93
Open
₹57.57
Volume
2.39L
Upper Circuit
₹61.11
Lower Circuit
₹40.75
Day's Low - High
₹49.99 - ₹59.98
52 Week Low - High
₹49.51 - ₹115.19

Valiant Laboratories Historical Returns

1 Month Return
-12.96 %
3 Month Return
-24.63 %
1 Year Return
-39.35 %
3 Year Return
-70.09 %
5 Year Return
-70.09 %

Valiant Laboratories Fundamentals

as on March 19, 2026 at 12:48 pm IST

Market Cap

₹276.61 Cr

Return on Equity (ROE)

-1.4

PE Ratio (TTM)

-70.57

Return on capital employed (ROCE)

-1.05

Industry PE ratio

41.24

Beta (LTM)

0

P/B Ratio

1.42

Dividend Yield

0

PEG Ratio

-327.08

Quarterly Earnings Growth YOY

-400.43

EPS (TTM)

-0.473339830154532

Sector

Pharmaceuticals

Book Value

50.05

Technical Analysis

Bullish

View Technical Analysis

Valiant Laboratories Stock Valuation

as on March 19, 2026 at 12:48 pm IST

Valiant Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (-248.57x)

June 13, 2025

Today (-70.57x)

March 18, 2026

Industry (41.24x)

March 18, 2026

Highest (4196.10x)

July 4, 2025

LowHigh

Today’s Price to Earnings Ratio: -70.57x

Valiant Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Valiant Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Valiant Laboratories Ltd image
Valiant Laboratories Ltd
NA276.61-14.02%0.67-3133
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA65.2713.56%0.004113
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA104.57-9.68%0.00-2743
Titan Biotech Ltd image
Titan Biotech Ltd
NA1,592.83189.17%0.5118156
Shilpa Medicare Ltd image
Shilpa Medicare Ltd
BUY6,348.5919.3%0.60781,286
See all

Valiant Laboratories Stock’s Investor Sentiment and Interest

Search interest for Valiant Laboratories Ltd Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

Valiant Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
89.92
51.41
59.55
40.52
30.59
18.88
21.48
35.23
57.79
46.82
46.2
52.46
Other Income
1.72
2.44
2.96
1.78
2.5
2.81
3.36
1.58
-2.31
0.66
0.87
0.63
Total Income
91.64
53.85
62.51
42.29
33.09
21.7
24.84
36.81
55.47
47.48
47.07
53.09
Expenses
81.31
47.59
60.93
46.82
35.12
21.27
28.22
34.61
53.96
44.42
46.12
53.35
Operating Profit
8.61
3.82
-1.38
-6.3
-4.53
-2.39
-6.74
0.62
3.83
2.4
0.08
-0.89
Operating Profit Margin %
9.58%
7.43%
-2.32%
-15.55%
-14.81%
-12.66%
-31.38%
1.76%
6.63%
5.13%
0.17%
-1.7%
Profit Before Interest, Tax and Depreciation
10.34
6.26
1.57
-4.53
-2.03
0.43
-3.38
2.2
1.51
3.05
0.94
-0.26
Interest
0.03
0.02
0.02
0.02
0.02
0.05
0.01
0.06
0.05
0.07
0.14
0.68
Depreciation
0.44
0.46
0.49
0.49
0.52
0.53
0.52
0.52
0.52
0.53
0.53
2.05
Profit Before Tax
9.87
5.78
1.06
-5.04
-2.57
-0.15
-3.91
1.62
0.94
2.45
0.27
-2.99
Tax Paid
2.04
1.51
0.27
-1.55
-1.33
0.35
0.83
-0.72
0.24
0.63
0.07
4.07
Profit After Tax
7.83
4.27
0.79
-3.5
-1.24
-0.51
-4.74
2.35
0.7
1.82
0.2
-7.06
Total Net profit including share of profit / Loss from associate company
7.83
4.27
0.79
-3.5
-1.24
-0.51
-4.74
2.35
0.7
1.82
0.2
-7.06
EPS
2.41
1.31
0.24
-0.81
-0.33
-0.13
-1.09
0.54
0.16
0.42
0.04
-1.3
Actual EPS
2.41
1.31
0.24
-0.81
-0.33
-0.13
-1.09
0.54
0.16
0.42
0.04
-1.3
Adjusted EPS
2.41
1.31
0.24
-0.75
-0.31
-0.12
-1.01
0.5
0.15
0.39
0.04
-1.3
Diluted EPS
2.41
1.31
0.24
-0.81
-0.33
-0.12
-1.09
0.54
0.16
0.42
0.04
-1.3

Valiant Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Sales
333.91
182.06
133.38
Other Income
4.86
9.68
5.43
Total Income
338.77
191.74
138.82
Expenses
298.82
190.46
138.06
Operating Profit
35.09
-8.4
-4.68
Operating Profit Margin %
10.51%
-4.61%
-3.51%
Profit Before Interest, Tax and Depreciation
39.95
1.27
0.76
Interest
0.25
0.08
0.18
Depreciation
1.56
1.97
2.09
Profit Before Tax
38.14
-0.78
-1.51
Tax Paid
9.14
-1.09
0.69
Profit After Tax
29
0.32
-2.2
Total Net profit including share of profit / Loss from associate company
29
0.32
-2.2
EPS
8.91
0.13
-0.51
Actual EPS
8.91
0.13
-0.51
Adjusted EPS
8.27
0.12
-0.47
Diluted EPS
8.91
0.13
-0.51

Valiant Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
56.05
1.89
1.31
Cash Flow from Investing Activities
-55.17
-143.87
-52.76
Cash Flow from Financing Activities
-0.94
152.45
44.65
Net Cash Flow
-0.05
10.46
-6.8

Valiant Laboratories Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Aug 2025
Sep 2025
Dec 2025
Promoters
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
74.94%
DII
3.89%
0.04%
0.02%
0.03%
0%
0%
0%
0%
0.46%
0%
0%
0%
FII
0%
0%
0%
3.48%
1.89%
0%
0%
0.64%
0.63%
0.52%
0.02%
0.01%
Public
12.53%
12.53%
17.51%
21.55%
23.17%
25.06%
25.06%
24.42%
23.97%
24.54%
25.04%
25.05%
Total Outstanding Shares
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
4,34,50,000
5,43,12,500
5,43,12,500
5,43,12,500
Total Shareholders
37,434
37,434
15,821
14,914
14,249
15,189
15,692
15,036
14,432
14,948
15,075
14,910

Valiant Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Valiant Laboratories.

  • Valiant Laboratories Ltd Earnings Results

    Valiant Laboratories Ltd’s net profit fell -400.43% since last year same period to ₹-7.06Cr in the Q3 2025-2026. On a quarterly growth basis, Valiant Laboratories Ltd has generated -3630% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Valiant Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.04% to 25.05% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 47.07 Cr → 53.09 Cr (in ₹), with an average increase of 11.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.94% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.02% to 0.01% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.82 Cr → -7.06 Cr (in ₹), with an average decrease of 1859.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VALIANTLAB stock has moved down by -5.8%

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17 1980. The said Partnership Firm M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16 2021 issued by the Central Registration Centre Registrar of Companies.The Company is an Active Pharmaceutical Ingredient API / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually commenced manufacturing of Paracetamol by late 1982. Paracetamol Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2 is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization WHO. Paracetamol has several applications such as usage in treatment of headaches muscle aches arthritis back aches toothaches cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form regular tablets effervescent tablets injection suppository and other forms. Paracetamol is often found combined with other drugs in many over the counter OTC allergy medications cold medications sleep medications pain relievers and other products. Presently the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area Boisar in the State of Maharashtra with an annual installed capacity of 9000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area Palghar Maharashtra the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora Director and Dhanvallabh Ventures LLP DVL. In July 2022 the Company formed its wholly owned subsidiary Valiant Advanced Sciences Private Limited VASPL to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11556000 Equity Shares through fresh issue..

Revenue: ₹52.46Cr as on December 2025 (Q3 FY26)
Net Profit: ₹-7.06Cr as on December 2025 (Q3 FY26)
Listing date: 06 Oct, 2023
Chairperson Name: Velji Gogri
OrganisationValiant Laboratories Ltd
IndustryPharmaceuticals
CEOVelji Gogri
E-voting on sharesClick here to vote

FAQs

What is Valiant Laboratories share price today?

Valiant Laboratories share price today stands at ₹57.57 as on . Valiant Laboratories share today touched a day high of ₹59.98 and a low of ₹49.99.

What is the 52 week high and 52 week low range for Valiant Laboratories share?

Valiant Laboratories touched a 52 week high of ₹115.19 and a 52 week low of ₹49.51. Valiant Laboratories share price today i.e. is trending at ₹57.57, which is -50.02% down from its 52 week high and 16.28% up from its 52 week low.

What is Valiant Laboratories's market capitalisation today?

Valiant Laboratories market capitalisation is ₹276.61 Cr as on .

How to buy Valiant Laboratories shares?

To buy Valiant Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VALIANTLAB or Valiant Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Valiant Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Valiant Laboratories trading volume today?

Valiant Laboratories trading volume is 2.39L as on . This means that 2.39L shares of Valiant Laboratories were bought and sold on the stock market during today's trading session.